UMN Pharma Inc. announced non consolidated earnings results for the year ended December 31, 2017. For the period, the company reported net sales of JPY 104 million compared with JPY 52 million for the same period a year ago. Operating loss was JPY 498 million compared with JPY 552 million for the same period a year ago. Ordinary loss was JPY 158 million compared with JPY 480 million for the same period a year ago. Net loss was JPY 159 million or JPY 12.96 per basic share compared with JPY 8,344 million or JPY 804.39 per basic share for the same period a year ago. Income before income taxes was JPY 158.422 million compared with JPY 8,346.743 million for the same period a year ago. Net cash used in operating activities was JPY 561.723 million.

The company provided earnings guidance for the full year of 2018. For the full year, the company expects to report net sales of JPY 102 million, operating loss of JPY 803 million, ordinary loss of JPY 809 million and net loss of JPY 810 million or JPY 63.31 per share.